|
Improvement in expert recommendations available in October 2002 as compared with January 2004. |
|||
| Programs |
2002 |
2004 |
Difference |
|
|
|||
| SG |
94% |
100% |
+6% |
| QID |
NA |
100% |
NA |
| JHABx |
61% |
99% |
+38% |
| 5MCC |
64% |
97% |
+33% |
| 5MID |
58% |
95% |
+37% |
| PMID |
24% |
52% |
+28% |
Burdette et al. Annals of Clinical Microbiology and Antimicrobials 2004 3:22 doi:10.1186/1476-0711-3-22 |
|||